Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

RNA Interference01:23

RNA Interference

26.7K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.7K
Experimental RNAi02:15

Experimental RNAi

6.4K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.4K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

17.2K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.2K
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

216
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
216

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rapid Access to Photoswitchable RNA Binders: Fluorination Enhances Protein Rescue by Exon Inclusion.

Chemistry (Weinheim an der Bergstrasse, Germany)·2026
Same author

ZNF274 constrains lineage plasticity and drives intrinsic resistance to CDK7 inhibitors in pancreatic cancer.

Nature communications·2026
Same author

SARS-CoV-2 Antivirals Identified from Small Molecule Modulators of Programmed -1 Ribosomal Frameshifting.

ACS infectious diseases·2026
Same author

The biased adenosine-rich content of the HIV-1 genome serves as a molecular signature that facilitates efficient packaging.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Self-Assembling RNA Nanostructures are Highly Sensitive to Environmental Conditions.

Journal of molecular biology·2025
Same author

Pervasive horizontal transfer of adeno-associated virus capsid genes.

Proceedings of the National Academy of Sciences of the United States of America·2025

Related Experiment Video

Updated: Oct 12, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.7K

Amilorides inhibit SARS-CoV-2 replication in vitro by targeting RNA structures.

Martina Zafferani1, Christina Haddad2, Le Luo2

  • 1Chemistry Department, Duke University, 124 Science Drive, Durham, NC 27705, USA.

Science Advances
|November 26, 2021
PubMed
Summary

New amiloride-based molecules effectively inhibit coronavirus replication by targeting conserved RNA structures in the viral 5′-end. These findings offer novel chemical probes for studying coronavirus RNA biology and developing new antiviral therapies.

More Related Videos

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

14.0K
High-throughput Antiviral Assays to Screen for Inhibitors of Zika Virus Replication
10:16

High-throughput Antiviral Assays to Screen for Inhibitors of Zika Virus Replication

Published on: October 30, 2021

3.9K

Related Experiment Videos

Last Updated: Oct 12, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.7K
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

14.0K
High-throughput Antiviral Assays to Screen for Inhibitors of Zika Virus Replication
10:16

High-throughput Antiviral Assays to Screen for Inhibitors of Zika Virus Replication

Published on: October 30, 2021

3.9K

Area of Science:

  • Virology
  • Medicinal Chemistry
  • Molecular Biology

Background:

  • The COVID-19 pandemic highlighted the critical need for novel antiviral drugs against coronaviruses (CoVs).
  • Small molecules can act as chemical probes to understand viral replication and as therapeutic leads.

Purpose of the Study:

  • To identify and characterize novel small molecules that inhibit coronavirus replication.
  • To explore amiloride derivatives as potential antivirals targeting conserved viral RNA structures.

Main Methods:

  • Screening of amiloride-based compounds for antiviral activity against OC43 and SARS-CoV-2.
  • Nuclear magnetic resonance (NMR) spectroscopy to determine drug-target interactions.
  • Retrospective molecular docking studies to predict binding affinity.

Main Results:

  • Identification of amiloride derivatives that potently inhibit OC43 and SARS-CoV-2 replication.
  • Structural studies revealed specific amiloride binding to stem-loop structures in the viral 5′-untranslated regions.
  • Lead amilorides showed strong predicted binding to these conserved RNA elements.

Conclusions:

  • Amilorides are the first small molecules demonstrated to target RNA structures in the 5′ untranslated regions of CoV genomes.
  • These amiloride compounds serve as valuable chemical probes for CoV RNA biology.
  • This work paves the way for developing novel, specific antiviral therapies targeting CoV RNA structures.